385 related articles for article (PubMed ID: 31466562)
1. Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies.
DePierro J; Lepow L; Feder A; Yehuda R
Biol Psychiatry; 2019 Sep; 86(6):454-463. PubMed ID: 31466562
[TBL] [Abstract][Full Text] [Related]
2. Understanding Resilience and Preventing and Treating PTSD.
Horn SR; Feder A
Harv Rev Psychiatry; 2018; 26(3):158-174. PubMed ID: 29734229
[TBL] [Abstract][Full Text] [Related]
3. Understanding resilience: New approaches for preventing and treating PTSD.
Horn SR; Charney DS; Feder A
Exp Neurol; 2016 Oct; 284(Pt B):119-132. PubMed ID: 27417856
[TBL] [Abstract][Full Text] [Related]
4. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
5. Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder.
Jones T; Moller MD
J Am Psychiatr Nurses Assoc; 2011; 17(6):393-403. PubMed ID: 22142976
[TBL] [Abstract][Full Text] [Related]
6. Future pharmacotherapy for post-traumatic stress disorder: prevention and treatment.
Friedman MJ
Psychiatr Clin North Am; 2002 Jun; 25(2):427-41. PubMed ID: 12136508
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy.
Dunlop BW; Mansson E; Gerardi M
Curr Pharm Des; 2012; 18(35):5645-58. PubMed ID: 22632469
[TBL] [Abstract][Full Text] [Related]
8. MDMA treatment paired with a trauma-cue promotes adaptive stress responses in a translational model of PTSD in rats.
Arluk S; Matar MA; Carmi L; Arbel O; Zohar J; Todder D; Cohen H
Transl Psychiatry; 2022 May; 12(1):181. PubMed ID: 35504866
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.
Bailey CR; Cordell E; Sobin SM; Neumeister A
CNS Drugs; 2013 Mar; 27(3):221-32. PubMed ID: 23483368
[TBL] [Abstract][Full Text] [Related]
10. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
[TBL] [Abstract][Full Text] [Related]
11. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions.
Dunlop BW; Wong A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():361-379. PubMed ID: 30342071
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
Bahji A; Forsyth A; Groll D; Hawken ER
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
[TBL] [Abstract][Full Text] [Related]
13. Exposure-related cortisol predicts outcome of psychotherapy in veterans with treatment-resistant posttraumatic stress disorder.
van Gelderen MJ; Nijdam MJ; de Vries F; Meijer OC; Vermetten E
J Psychiatr Res; 2020 Nov; 130():387-393. PubMed ID: 32889356
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder.
Donnelly CL
Child Adolesc Psychiatr Clin N Am; 2003 Apr; 12(2):251-69. PubMed ID: 12725011
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment cortisol predicts trauma-focused psychotherapy response in youth with (partial) posttraumatic stress disorder.
Zantvoord JB; Ensink JBM; Op den Kelder R; Wessel AMA; Lok A; Lindauer RJL
Psychoneuroendocrinology; 2019 Nov; 109():104380. PubMed ID: 31352130
[TBL] [Abstract][Full Text] [Related]
16. Neurobiology of posttraumatic stress disorder.
Heim C; Nemeroff CB
CNS Spectr; 2009 Jan; 14(1 Suppl 1):13-24. PubMed ID: 19169190
[TBL] [Abstract][Full Text] [Related]
17. Increased Resilience is Associated with Positive Treatment Outcomes for Veterans with Comorbid PTSD and Substance Use Disorders.
McGuire AP; Mota NP; Sippel LM; Connolly KM; Lyons JA
J Dual Diagn; 2018; 14(3):181-186. PubMed ID: 29668364
[TBL] [Abstract][Full Text] [Related]
18. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
[TBL] [Abstract][Full Text] [Related]
19. Posttraumatic stress disorder: from diagnosis to prevention.
Miao XR; Chen QB; Wei K; Tao KM; Lu ZJ
Mil Med Res; 2018 Sep; 5(1):32. PubMed ID: 30261912
[TBL] [Abstract][Full Text] [Related]
20. Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder.
Gonda X; Dome P; Erdelyi-Hamza B; Krause S; Elek LP; Sharma SR; Tarazi FI
Eur Neuropsychopharmacol; 2022 Aug; 61():17-29. PubMed ID: 35716404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
